5 Stocks With Ugly Sales Growth — ACHN DSCO FOLD UPIP ARIA

by Portfolio Grader | November 26, 2012 8:09 pm

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader[1].

Achillion (NASDAQ:ACHN[2]) focuses on the discovery, development and commercialization of innovative treatments for infectious diseases. ACHN also gets an F in Equity. For more information, get Portfolio Grader’s complete analysis of ACHN stock[3].

Discovery Laboratories (NASDAQ:DSCO[4]) is a biotechnology company focused on developing products for the treatment of respiratory disease. DSCO gets F’s in Equity and Cash Flow as well. For more information, get Portfolio Grader’s complete analysis of DSCO stock[5].

Amicus Therapeutics (NASDAQ:FOLD[6]) is a biopharmaceutical company which is focused on the discovery, development and commercialization of orally-administered, small molecule drugs known as pharmacological chaperones. FOLD gets F’s in Analyst Earnings Revisions, Equity, and Cash Flow as well. For more information, get Portfolio Grader’s complete analysis of FOLD stock[7].

Unwired Planet (NASDAQ:UPIP[8]) provides open Internet-based communication infrastructure software and applications. UPIP also gets F’s in Earnings Growth, Analyst Earnings Revisions, Equity, Cash Flow, and Operating Margin Growth. For more information, get Portfolio Grader’s complete analysis of UPIP stock[9].

Ariad Pharmaceuticals (NASDAQ:ARIA[10]) is an oncology company that focuses on the discovery, development, and commercialization of medicines for cancer patients. ARIA also gets F’s in Earnings Growth and Equity. For more information, get Portfolio Grader’s complete analysis of ARIA stock[11].

Louis Navellier’s proprietary Portfolio Grader[1] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[12].

Endnotes:

  1. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  2. ACHN: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=ACHN
  3. For more information, get Portfolio Grader’s complete analysis of ACHN stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=ACHN
  4. DSCO: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=DSCO
  5. For more information, get Portfolio Grader’s complete analysis of DSCO stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=DSCO
  6. FOLD: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=FOLD
  7. For more information, get Portfolio Grader’s complete analysis of FOLD stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=FOLD
  8. UPIP: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=UPIP
  9. For more information, get Portfolio Grader’s complete analysis of UPIP stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=UPIP
  10. ARIA: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=ARIA
  11. For more information, get Portfolio Grader’s complete analysis of ARIA stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=ARIA
  12. here: https://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: https://investorplace.com/2012/11/5-stocks-with-ugly-sales-growth-achn-dsco-fold-upip-aria-achn-dsco-fold-upip-aria/

Copyright ©2024 InvestorPlace unless otherwise noted.